ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	38/678	73/6026	6.04082556095241e-18	2.84522883920859e-15	2.39089516938748e-15	6356/6357/6362/6347/6364/6368/6369/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3589/3605/3552/3553/3557/11009/90865/3569/4312/4314/5008/5196/6696/8741	38
WP5055	Burn wound healing	44/678	97/6026	1.27147610753485e-17	2.99432623324457e-15	2.51618429701634e-15	8038/6347/57124/1139/1277/1278/2919/3579/1634/2200/2335/10468/3082/3383/3552/3553/3569/3624/3791/3853/3956/23643/407024/4312/4322/4313/79148/4314/100463486/64332/64127/5159/6282/6280/8796/871/6423/6678/7042/7043/7076/7097/51311/3371	44
WP2806	Complement system	36/678	75/6026	1.33195482179103e-15	2.09116907021191e-13	1.75724565962606e-13	133/715/716/717/719/720/722/728/27202/729/1604/22918/629/3075/3426/5199/10332/1380/1634/2214/2219/2357/2769/3383/3673/3687/3690/3915/5648/5329/5806/6401/6403/710/6696/7097	36
WP558	Complement and coagulation cascades	27/678	48/6026	3.31440016986152e-14	3.90270620001194e-12	3.27951174702087e-12	712/713/715/716/717/719/721/728/729/1604/629/3075/3426/1380/2149/2153/2155/3827/5648/5327/5328/5329/5104/5054/710/7056/7450	27
WP5115	Network map of SARS-CoV-2 signaling pathway	56/678	189/6026	2.27147455874732e-12	2.13972903433997e-10	1.79805144018735e-10	350/8542/684/715/716/6356/6347/6364/6348/6351/6355/9332/1051/629/3075/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/2247/2335/3091/10964/2537/8519/10410/3458/3605/8807/3552/3553/90865/3569/3699/116844/64386/114548/5196/5743/6288/6289/6403/5104/5054/6772/7018	56
WP455	GPCRs, class A rhodopsin-like	39/678	118/6026	1.56251881466442e-10	1.22657726951157e-08	1.03071416546284e-08	134/147/187/719/27202/1230/729230/1232/1237/10803/3577/3579/1909/2149/2151/9002/2867/2357/2358/2359/54328/2842/2850/2861/2828/8111/8843/3274/64106/4886/4887/5540/53829/9934/5031/5724/5737/5739/56670	39
WP2911	miRNA targets in ECM and membrane receptors	15/678	22/6026	4.05672140530614e-10	2.7295939741417e-08	2.29372518555655e-08	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/22801/3910/3915/7058	15
WP3624	Lung fibrosis	23/678	52/6026	1.54833265775221e-09	9.11580852251613e-08	7.66017209624777e-08	6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/2247/2252/26585/3082/3553/3569/4313/5155/5328/5806/6696/7015/7076	23
WP545	Complement activation	12/678	18/6026	3.67054399617343e-08	1.88707504303139e-06	1.58574190676009e-06	712/713/715/716/717/720/721/729/1604/629/5199/5648	12
WP5090	Complement system in neuronal development and plasticity	30/678	93/6026	4.00652875378213e-08	1.88707504303139e-06	1.58574190676009e-06	712/713/715/716/717/719/720/721/722/725/728/27202/729/1604/629/3075/3426/5199/10584/1380/6376/2219/8547/3458/3687/3690/5648/710/7042/7043	30
WP24	Peptide GPCRs	18/678	41/6026	1.10694628432655e-07	4.73974272652548e-06	3.9828880660936e-06	719/728/1230/729230/1232/1237/10803/3577/3579/1909/2357/2358/2359/4886/4887/5540/6869/7253	18
WP2431	Spinal cord injury	30/678	98/6026	1.50226553335359e-07	5.87370211030313e-06	4.93577381489323e-06	199/301/63827/713/6347/729230/1280/1282/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/4321/4843/9423/5743/6098/6403/6869/8741/1462	30
WP2865	IL1 and megakaryocytes in obesity	13/678	23/6026	1.62119166526413e-07	5.87370211030313e-06	4.93577381489323e-06	6347/1232/2149/3383/3458/3553/3554/114548/7941/6280/8991/7076/7097	13
WP5088	Prostaglandin signaling	14/678	28/6026	4.05793413184575e-07	1.36520498292811e-05	1.14720543877744e-05	834/6347/6348/729230/2919/3627/4283/3458/3605/3552/3553/3569/114548/9536	14
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	57/678	265/6026	6.39409959066577e-07	2.00774727146905e-05	1.68714487444935e-05	284/285/1302/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3091/3559/3563/22801/3673/3678/8516/3687/3690/3791/284217/3908/3910/3915/10319/4843/4846/5008/9180/5155/5159/5209/5228/6515/6696/7010/7058/3371/7143/7450	57
WP2848	Pluripotent stem cell differentiation pathway	15/678	34/6026	1.19835872271258e-06	3.52766848998517e-05	2.9643610509206e-05	3577/2255/2247/10468/3082/3589/3569/3624/10637/5155/6469/7018/7043/7472/7474	15
WP129	Matrix metalloproteinases	12/678	24/6026	2.80883846665989e-06	7.41744236145612e-05	6.23300553784222e-05	4312/4319/4321/4322/4323/4327/4313/64386/79148/4314/4316/7076	12
WP3967	miR-509-3p alteration of YAP1/ECM axis	10/678	17/6026	2.83469134832718e-06	7.41744236145612e-05	6.23300553784222e-05	1277/1281/1289/1909/2335/10082/6678/7004/7058/7291	10
WP619	Type II interferon signaling	14/678	34/6026	7.3651935955549e-06	0.000176769340103365	0.0001485423441253	3627/4283/2633/3383/2537/3458/3553/4843/5698/8651/9021/6688/6772/6890	14
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20/678	62/6026	7.50612909143801e-06	0.000176769340103365	0.0001485423441253	6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/84868/8519/3569/5196/6772/7020	20
WP4172	PI3K-Akt signaling pathway	55/678	280/6026	1.82923731048814e-05	0.00040220204590267	0.000337977358943801	284/285/1277/1278/1280/1282/1284/1291/1292/1293/131873/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3559/3563/3569/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/4846/4915/5008/9180/5155/5159/5228/8503/10110/6696/7010/7058/7097/3371/7143/7450	55
WP2328	Allograft rejection	22/678	76/6026	1.87865074519294e-05	0.00040220204590267	0.000337977358943801	23743/712/713/717/720/721/729/1604/941/942/1289/6373/4283/50943/3002/3458/3605/3552/3553/3559/120892/6772	22
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/678	24/6026	2.12059613382105e-05	0.000434261208273788	0.000364917229435567	6348/6351/1230/729230/1232/1437/3458/3595/8809/7042/7043	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/678	17/6026	2.89122545867733e-05	0.000567402996265426	0.000476798584413454	6347/3383/3553/5196/6401/6403/7042/7043/7097	9
WP4754	IL-18 signaling pathway	48/678	239/6026	3.49251091194696e-05	0.000657989055810807	0.00055291962227034	59/11096/6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/2920/2921/2335/2523/338442/3383/3458/10068/8809/8807/3553/3559/3569/81618/4312/4322/4323/4313/4314/4688/4776/64332/4843/51299/7941/5743/5806/9021/6696/6869/7018/7052/7076/7127/79931/80149	48
WP5087	Malignant pleural mesothelioma	68/678	381/6026	5.13649168586532e-05	0.000930495224631756	0.00078191128497383	59/9510/284/285/834/6347/6351/29126/1009/1012/1014/1001/1003/1004/1282/1284/1437/1440/115908/2919/3627/6374/1944/2255/2247/2252/2321/2335/8061/11211/3082/3091/3620/3553/3569/3673/3690/3791/284217/3908/3910/3915/10319/26524/4323/4313/4314/114548/4915/5155/5159/5163/5228/5328/4920/6401/6422/6423/8140/64321/6678/6772/7004/7010/7015/7472/7474/25937	68
WP530	Cytokines and inflammatory response	9/678	19/6026	8.91553274561511e-05	0.00155526515673508	0.00130691630111161	1437/1440/2919/2920/3458/3589/3552/3553/3569	9
WP1533	Vitamin B12 metabolism	13/678	37/6026	0.000112233193771977	0.00188792265237861	0.00158645416760388	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648/6947	13
WP3617	Photodynamic therapy-induced NF-kB survival signaling	12/678	33/6026	0.000141040862919417	0.0022906981529326	0.00192491341044286	597/1437/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	12
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	18/678	65/6026	0.000199745037203714	0.00308026741458872	0.002588402163114	947/2354/8456/94234/10468/2619/284110/3458/3488/5653/5650/8549/4488/22822/6275/6422/11005/7474	18
WP4891	COVID-19 adverse outcome pathway	7/678	13/6026	0.000206361819132616	0.00308026741458872	0.002588402163114	6347/6348/1440/3627/3553/3559/3569	7
WP2877	Vitamin D receptor pathway	31/678	143/6026	0.000209275068507089	0.00308026741458872	0.002588402163114	11096/147/768/634/9075/1543/1594/1555/1577/168002/1673/50486/3091/3488/9173/5653/3827/126364/639/5744/6273/6275/6279/6280/6422/219855/6696/79689/7042/7056/54210	31
WP2849	Hematopoietic stem cell differentiation	14/678	46/6026	0.000349570855078431	0.00498932947702852	0.00419262014384339	947/1437/1440/2354/2624/3552/3553/3569/3690/4582/4778/861/6688/7068	14
WP474	Endochondral ossification	16/678	57/6026	0.000377955546351339	0.00508620178089944	0.00427402362189785	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP4808	Endochondral ossification with skeletal dysplasias	16/678	57/6026	0.000377955546351339	0.00508620178089944	0.00427402362189785	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	12/678	37/6026	0.000481548092121703	0.00630025420525895	0.00529421294262457	84674/834/50506/3553/4210/4671/58484/91662/114548/64127/639/8767	12
WP15	Selenium micronutrient network	16/678	59/6026	0.000577395206704616	0.0073500849285912	0.00617640391809205	19/247/6347/2155/3383/3458/3553/3569/8942/5327/10549/5743/6288/6289/5054/6648	16
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/678	28/6026	0.000601169210370683	0.00745133416012083	0.00626148540441487	6347/29126/941/942/3627/3559/8651/7042/7043/51311	10
WP5097	CCL18 signaling pathway	12/678	39/6026	0.000822550699477055	0.00993388152445366	0.00834761303652828	59/1237/1278/1437/2335/3091/4313/6615/6772/7004/7020/7291	12
WP306	Focal adhesion	35/678	183/6026	0.00102098355942585	0.0120220814122394	0.0101023636406347	87/1277/1278/1280/1282/1284/1290/50509/1292/2268/2321/2335/3055/3082/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/5155/5159/5228/8503/399694/6696/7058/3371/7143/7450	35
WP5094	Orexin receptor pathway	24/678	112/6026	0.00125751140845869	0.0144460456922937	0.0121392628903842	2920/1846/2354/3091/9456/3383/3553/3569/3777/3908/4023/23764/7873/4322/4314/4846/64106/8013/5069/5163/861/6401/6696/3371	24
WP453	Inflammatory response pathway	9/678	26/6026	0.00145771827849532	0.0163472692659832	0.0137368940529885	941/942/1277/1278/1281/2335/3458/3559/3915	9
WP4823	Genes controlling nephrogenesis	10/678	32/6026	0.00194684149526428	0.0213247056806855	0.0179195202501682	2296/2737/3237/8516/3791/4868/5155/5159/6092/6469	10
WP716	Vitamin A and carotenoid metabolism	10/678	34/6026	0.00321429480012883	0.0344075647922881	0.0289132738002019	127/8854/83875/1381/1382/56603/4023/29881/116362/195814	10
WP1539	Angiogenesis	8/678	24/6026	0.00349771771154153	0.0366094453808013	0.0307635522699325	284/2247/2321/3091/3791/4846/5155/7010	8
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10/678	35/6026	0.00405650856531124	0.0406868511890108	0.0341898671294403	284/285/597/3091/3485/4843/5743/5054/6515/7043	10
WP272	Blood clotting cascade	6/678	15/6026	0.00406004672162104	0.0406868511890108	0.0341898671294403	2153/2155/5327/5328/5054/7450	6
WP5092	Interactions of natural killer cells in pancreatic cancer	8/678	25/6026	0.00464630148699607	0.0455918333411489	0.0383116087524237	6347/6348/6351/1437/2214/2624/3002/3458	8
WP4496	Signal transduction through IL1R	9/678	31/6026	0.00562057484495014	0.0534811620141827	0.0449411485469498	3552/3553/3554/3556/3557/3569/11213/7042/7043	9
WP176	Folate metabolism	12/678	48/6026	0.00567740573398967	0.0534811620141827	0.0449411485469498	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648	12
WP4493	Cells and molecules involved in local acute inflammatory response 	6/678	16/6026	0.00588707990203926	0.0543689143894214	0.0456871422738238	729/3383/3552/3569/3827/6403	6
WP117	GPCRs, other	10/678	37/6026	0.00625717526507937	0.056675568266392	0.0476254635560697	27202/3577/3579/1909/2149/11245/53831/59340/53829/5737	10
WP5222	2q13 copy number variation syndrome	12/678	49/6026	0.00677056893060756	0.0601686408738898	0.0505607530865629	55289/1437/3552/3553/3554/3556/8808/3557/3569/8651/9021/6772	12
WP5188	Retinol metabolism	5/678	12/6026	0.00715324594168874	0.0623922007136184	0.0524292490073093	316/1543/1551/10170/195814	5
WP2197	Endothelin pathways	8/678	27/6026	0.00778615469090685	0.066322095719554	0.0557316079797794	10203/1909/2769/51764/4846/4886/23236/5739	8
WP4541	Hippo-Merlin signaling dysregulation	20/678	101/6026	0.00788542963969219	0.066322095719554	0.0557316079797794	1009/1012/1014/1001/1003/1004/3627/2321/22801/3673/3678/8516/3687/3690/3791/26524/4915/5159/7004/7010	20
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/678	22/6026	0.00828150333626452	0.0684313696733437	0.0575040674872661	2919/2920/2247/3553/5155/6469/30812	7
WP3937	Microglia pathogen phagocytosis pathway	10/678	39/6026	0.00928921197429968	0.0741562515236466	0.0623147850550701	712/713/2207/2209/3055/4688/8503/54210/54209/7305	10
WP4329	miRNAs involvement in the immune response in sepsis	10/678	39/6026	0.00928921197429968	0.0741562515236466	0.0623147850550701	6348/6351/3002/3383/3552/3569/3934/407008/407024/51311	10
WP3929	Chemokine signaling pathway	27/678	152/6026	0.0102456970337347	0.0804287217148173	0.0675856506084955	6356/6364/6369/6348/6351/1230/729230/1232/1237/10803/6376/3627/6373/2921/6374/4283/3579/2268/59345/2791/51764/3055/5196/8503/23236/399694/6772	27
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	12/678	52/6026	0.0110664205214997	0.0854472797643665	0.0718028320290576	1003/1277/1278/2321/3082/3791/4313/8829/91584/6615/7042/7043	12
WP5198	Inflammatory bowel disease signaling	9/678	35/6026	0.0130773568763558	0.0993457272381223	0.0834819386334429	50943/3458/3595/8807/3552/3569/64127/6772/7097	9
WP98	Prostaglandin synthesis and regulation	10/678	41/6026	0.0133323610974297	0.0996752710617365	0.0837588600272945	1645/301/308/1909/3290/9536/5737/5739/5743/6916	10
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/678	134/6026	0.013572513430493	0.0998852160275344	0.0839352804254172	9076/51208/9075/9073/1282/1284/2335/94234/11211/3091/3678/26524/4313/4854/4855/8828/8503/6615/6678/7042/7043/7291/7472/7474	24
WP12	Osteoclast signaling	5/678	14/6026	0.0149389931777815	0.10501889233933	0.0882491977194947	1513/8111/3690/5155/6696	5
WP4210	Tryptophan catabolism leading to NAD+ production	5/678	14/6026	0.0149389931777815	0.10501889233933	0.0882491977194947	3620/8942/10135/23057/6999	5
WP5063	FOXP3 in COVID-19	5/678	14/6026	0.0149389931777815	0.10501889233933	0.0882491977194947	941/942/50943/3559/3569	5
WP5083	Neuroinflammation and glutamatergic signaling	21/678	115/6026	0.0163829987322048	0.113476358865713	0.0953561536115945	816/1610/2247/2898/2906/116443/3458/3552/3553/3554/3569/80131/23236/29968/6507/6515/92745/9021/6772/7042/7043	21
WP2406	Cardiac progenitor differentiation	8/678	31/6026	0.0184834095550281	0.126169360875627	0.10602230347354	2247/2626/3624/3791/3084/4920/64321/7070	8
WP1992	Genes targeted by miRNAs in adipocytes	4/678	10/6026	0.0191330795744193	0.128738292565021	0.108181021353107	2078/2697/9464/3759	4
WP727	Monoamine transport	6/678	21/6026	0.0244843360006583	0.162424257131127	0.136487921960675	273/3553/3554/3690/6853/6999	6
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7/678	27/6026	0.0262561978742967	0.167114891944105	0.1404295437948	6347/2977/3553/3569/4312/4314/23657	7
WP465	Tryptophan metabolism	8/678	33/6026	0.0266217312397547	0.167114891944105	0.1404295437948	8854/316/1543/1545/9420/3620/8942/6999	8
WP5218	Extrafollicular B cell activation by SARS-CoV-2	13/678	65/6026	0.0268515356036596	0.167114891944105	0.1404295437948	57379/60468/720/941/1380/8519/3458/3569/3687/639/57823/8741/7494	13
WP3413	NOTCH1 regulation of endothelial cell calcification	5/678	16/6026	0.0269654602712356	0.167114891944105	0.1404295437948	249/813/2702/4256/5327	5
WP4478	LTF danger signal response pathway	5/678	16/6026	0.0269654602712356	0.167114891944105	0.1404295437948	3552/3553/3569/7097/54210	5
WP4707	Aspirin and miRNAs	4/678	11/6026	0.0274417128569276	0.167857750072895	0.141053780371904	283120/4846/5163/5743	4
WP4747	Netrin-UNC5B signaling pathway	10/678	46/6026	0.0290502249555048	0.175418666077471	0.147407349301887	249/6347/1003/1277/3383/3552/3791/9423/54538/6401	10
WP3941	Oxidative damage response	9/678	40/6026	0.030494585869546	0.181809492969065	0.152777672044628	712/713/715/716/717/719/721/728/1380	9
WP4008	NO/cGMP/PKG mediated neuroprotection	8/678	34/6026	0.0315029684926634	0.185473727000556	0.155856791490019	816/1261/2906/2977/3458/3553/4843/4846	8
WP289	Myometrial relaxation and contraction pathways	22/678	131/6026	0.0345153689794204	0.197278840116584	0.165776832906102	59/133/816/2697/59345/2791/51764/2981/3485/3488/3553/3569/23764/4846/5142/5333/10266/10268/64407/5999/8490/8787	22
WP3287	Overview of nanoparticle effects	5/678	17/6026	0.0347646363687398	0.197278840116584	0.165776832906102	1001/1282/2335/3569/5743	5
WP4830	GDNF/RET signaling axis	5/678	17/6026	0.0347646363687398	0.197278840116584	0.165776832906102	2296/2737/26585/6092/64321	5
WP3527	Pre-implantation embryo	8/678	35/6026	0.0369624089715693	0.203401454623249	0.170921772127258	366/55509/2354/94234/2624/4603/30812/7004	8
WP4136	Fibrin complement receptor 3 signaling pathway	8/678	35/6026	0.0369624089715693	0.203401454623249	0.170921772127258	6347/3627/2921/3569/23643/4843/5327/7305	8
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	13/678	68/6026	0.0375479148779477	0.203401454623249	0.170921772127258	816/6347/1594/1673/10964/3458/3569/64127/23236/5333/6772/7097/51311	13
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/678	12/6026	0.037585946314547	0.203401454623249	0.170921772127258	2099/2335/8061/7076	4
WP4538	Regulatory circuits of the STAT3 signaling pathway	14/678	75/6026	0.0380028195474435	0.203401454623249	0.170921772127258	1271/1438/1439/1441/2149/2151/9002/3595/3601/3559/3563/9180/5159/9021	14
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/678	18/6026	0.0438212932060069	0.22933143444477	0.192711184157411	308/1280/2252/2335/3490	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/678	18/6026	0.0438212932060069	0.22933143444477	0.192711184157411	1014/1004/2335/6615/3371	5
WP75	Toll-like receptor signaling pathway	15/678	84/6026	0.0459741853655728	0.237954300078954	0.199957127790114	6348/6351/941/942/3627/6373/4283/3553/3569/23643/8503/6696/6772/7097/51311	15
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	21/678	128/6026	0.047629525385523	0.24384246148458	0.204905052001792	116/720/721/1051/1103/1139/2328/2624/2697/3091/3359/3552/3553/3557/3569/3764/4915/6507/6869/7018/7068	21
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/678	13/6026	0.0495957471489751	0.246437390070186	0.207085615524393	2180/2182/54898/3992	4
WP4724	Omega-9 fatty acid synthesis	4/678	13/6026	0.0495957471489751	0.246437390070186	0.207085615524393	2180/2182/54898/3992	4
WP4331	Neovascularisation processes	8/678	37/6026	0.049706055322012	0.246437390070186	0.207085615524393	284/3091/3791/4854/4855/5155/7042/7043	8
WP4969	RAS and bradykinin pathways in COVID-19	6/678	25/6026	0.0543559216917615	0.266683740800205	0.224098975395859	3552/3553/3827/4846/5054/710	6
WP43	Oxidation by cytochrome P450	8/678	38/6026	0.0570258272133146	0.276898604303827	0.232682702465614	1543/1545/56603/1594/1555/1577/1551/9420	8
WP3971	OSX and miRNAs in tooth development	4/678	14/6026	0.0634584487374525	0.304989075054491	0.256287612516457	249/407024/4854/4855	4
WP5053	Development of ureteric collection system	10/678	53/6026	0.068340778580533	0.325136431428597	0.27321778571271	2296/80144/341640/10468/2737/3237/8516/6092/6469/7042	10
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/678	27/6026	0.0750698834303983	0.353579150957176	0.297118696524524	247/3488/23236/9536/5743/6916	6
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10/678	54/6026	0.0758423990234441	0.353680890495467	0.297204190024127	25805/2022/2200/10468/3458/3624/10637/5054/6696/6772	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4/678	15/6026	0.0791238968580311	0.361818984661482	0.304042771779455	19/9388/4023/255738	4
WP5174	Ulcerative colitis signaling	4/678	15/6026	0.0791238968580311	0.361818984661482	0.304042771779455	50943/3458/64127/7097	4
WP1591	Heart development	7/678	34/6026	0.0802555278810455	0.363464938768966	0.305425895579687	2255/2296/2626/9464/23493/4776/6469	7
WP4540	Hippo signaling regulation pathways	14/678	84/6026	0.0845656845685468	0.379337499350339	0.318763883686953	1009/1012/1014/1001/1003/1004/2321/3791/26524/4915/5159/23236/7004/7010	14
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	6/678	28/6026	0.0868914220030706	0.386093016636285	0.324440662096867	9509/1277/1278/60681/4015/871	6
WP236	Adipogenesis	18/678	115/6026	0.0910688714704311	0.397204799847808	0.333778086362222	1051/1271/56603/2624/2626/3091/3569/4023/10135/5008/5346/5054/8651/9021/6695/6772/7291/25937	18
WP2371	Parkinson's disease pathway	7/678	35/6026	0.0910788076084147	0.397204799847808	0.333778086362222	2861/120892/100506755/6622/9627/9246/7345	7
WP1423	Ganglio sphingolipid metabolism	3/678	10/6026	0.0931845430226713	0.402659814345671	0.338362029710521	8708/2523/30815	3
WP247	Small ligand GPCRs	4/678	16/6026	0.096510042386963	0.4095155852636	0.344123052987179	5724/5737/5739/9294	4
WP516	Hypertrophy model	4/678	16/6026	0.096510042386963	0.4095155852636	0.344123052987179	3458/3552/3554/8013	4
WP2374	Oncostatin M signaling pathway	11/678	64/6026	0.0992366637561426	0.417325612760207	0.35068595462697	6347/1051/3091/4312/4322/4314/5008/9180/5054/9021/6772	11
WP560	TGF-beta receptor signaling	9/678	50/6026	0.102817272656349	0.42855695062956	0.360123842746037	25805/2022/10468/3458/3624/10637/5054/6696/6772	9
WP2880	Glucocorticoid receptor pathway	11/678	65/6026	0.10800138466969	0.439423108930922	0.369254864136835	6347/6364/3589/89795/5142/5743/5272/1836/5552/7056/84951	11
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/678	23/6026	0.108223101137977	0.439423108930922	0.369254864136835	285/2022/2200/10631/5054	5
WP3893	Development and heterogeneity of the ILC family	5/678	23/6026	0.108223101137977	0.439423108930922	0.369254864136835	3458/3605/3553/90865/3569	5
WP3874	Canonical and non-canonical TGF-B signaling	4/678	17/6026	0.115508628854108	0.457181211683068	0.384177306051701	26585/4015/4016/4017	4
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4/678	17/6026	0.115508628854108	0.457181211683068	0.384177306051701	249/1594/6098/6696	4
WP691	Tamoxifen metabolism	4/678	17/6026	0.115508628854108	0.457181211683068	0.384177306051701	1543/1545/1577/2328	4
WP3630	NAD metabolism, sirtuins and aging	3/678	11/6026	0.117838104334825	0.458692125138039	0.385446952848145	3091/10135/6098	3
WP5052	Nephrogenesis	3/678	11/6026	0.117838104334825	0.458692125138039	0.385446952848145	8854/4211/84870	3
WP2858	Ectoderm differentiation	18/678	120/6026	0.123571757087949	0.477068013019867	0.400888530328461	91653/6347/1004/54898/2737/57476/9687/3853/9079/4061/22871/5783/4920/6469/6622/6781/7020/7022	18
WP5036	Angiotensin II receptor type 1 pathway	5/678	24/6026	0.124737761612211	0.477654355441882	0.401381244041005	59/1277/1278/3091/3589	5
WP3927	BMP signaling in eyelid development	4/678	18/6026	0.135990724753566	0.515765176374045	0.433406428241459	2255/2296/6422/6469	4
WP2064	Neural crest differentiation	11/678	68/6026	0.136880354664025	0.515765176374045	0.433406428241459	1004/1302/1280/2247/23493/4488/4854/4855/6615/7020/7291	11
WP4565	Neural crest cell migration in cancer	7/678	39/6026	0.141950902932534	0.519414648744145	0.436473143206612	1009/2047/2151/4313/4915/8503/7291	7
WP5130	Th17 cell differentiation pathway	10/678	61/6026	0.142083819337516	0.519414648744145	0.436473143206612	50943/3091/3458/3605/3553/3559/3569/861/9021/6772	10
WP4900	Purinergic signaling	5/678	25/6026	0.142333221592324	0.519414648744145	0.436473143206612	134/5027/53829/9934/5031	5
WP2881	Estrogen receptor pathway	3/678	12/6026	0.144588823674918	0.519414648744145	0.436473143206612	1543/1545/2099	3
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/678	12/6026	0.144588823674918	0.519414648744145	0.436473143206612	55509/1437/6688	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/678	12/6026	0.144588823674918	0.519414648744145	0.436473143206612	3552/3569/6772	3
WP2882	Nuclear receptors meta-pathway	36/678	268/6026	0.145568436590716	0.519414648744145	0.436473143206612	8647/874/6347/6364/1543/1545/1555/1577/1551/2099/3082/3458/3589/3553/55554/23764/89795/3084/5142/5155/9588/5743/5272/1836/154091/6515/29986/160728/11254/23657/8140/5552/27286/7042/7056/84951	36
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5/678	26/6026	0.160931036792576	0.561470506142986	0.471813410011762	9536/5737/5739/5743/6916	5
WP4875	Disruption of postsynaptic signaling by CNV	5/678	26/6026	0.160931036792576	0.561470506142986	0.471813410011762	816/2906/9456/22871/57555	5
WP5121	Sphingolipid metabolism in senescence	5/678	26/6026	0.160931036792576	0.561470506142986	0.471813410011762	23236/9294/55512/8877/7015	5
WP3646	Hepatitis C and hepatocellular carcinoma	8/678	48/6026	0.165732644712004	0.573971144554071	0.482317913403354	1284/3577/3091/3569/4312/4843/5743/7345	8
WP4298	Acute viral myocarditis	12/678	79/6026	0.172645213560799	0.578183387687958	0.485857534407581	199/834/1232/1604/941/3458/3569/3908/64127/6444/8651/6772	12
WP1434	Osteopontin signaling	3/678	13/6026	0.173086746632701	0.578183387687958	0.485857534407581	3690/5328/6696	3
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3/678	13/6026	0.173086746632701	0.578183387687958	0.485857534407581	249/6422/7015	3
WP3958	GPR40 pathway	3/678	13/6026	0.173086746632701	0.578183387687958	0.485857534407581	23236/5333/113026	3
WP554	ACE inhibitor pathway	3/678	13/6026	0.173086746632701	0.578183387687958	0.485857534407581	1511/3827/4846	3
WP167	Eicosanoid synthesis	4/678	20/6026	0.180817144838473	0.591422744575839	0.496982795754868	247/9536/5743/6916	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/678	20/6026	0.180817144838473	0.591422744575839	0.496982795754868	2626/3569/3791/6696	4
WP5044	Kynurenine pathway and links to cell senescence	4/678	20/6026	0.180817144838473	0.591422744575839	0.496982795754868	3620/3458/8942/6999	4
WP364	IL6 signaling pathway	7/678	42/6026	0.187334365673764	0.608513698154089	0.511344620641273	3055/3569/639/9021/6772/7076/7432	7
WP2324	AGE/RAGE pathway	10/678	65/6026	0.190092514597854	0.613243660106776	0.515319289753376	249/3091/4322/4323/4313/4316/4481/4843/4846/6772	10
WP4561	Cell migration and invasion through p75NTR	5/678	28/6026	0.200782655562438	0.634749483726734	0.533391006551015	1009/1944/4313/4915/7291	5
WP1602	Nicotine effect on dopaminergic neurons	3/678	14/6026	0.202985373331405	0.634749483726734	0.533391006551015	1138/3777/6571	3
WP3935	Leptin-insulin signaling overlap	3/678	14/6026	0.202985373331405	0.634749483726734	0.533391006551015	8503/8651/9021	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/678	14/6026	0.202985373331405	0.634749483726734	0.533391006551015	941/942/8503	3
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	7/678	43/6026	0.203646862246605	0.634749483726734	0.533391006551015	816/2906/116443/9456/4915/8503/85358	7
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/678	21/6026	0.20484484400523	0.634749483726734	0.533391006551015	941/942/3101/6515	4
WP4564	Neural crest cell migration during development	6/678	36/6026	0.212853397392343	0.655254576286231	0.55062179167197	1009/2047/2151/4313/8503/7291	6
WP4018	Clear cell renal cell carcinoma pathways	12/678	83/6026	0.219022202400268	0.669866606042378	0.56290053385168	1012/2321/3091/3101/3759/3791/5155/5159/29968/10993/7042/7043	12
WP2118	Arrhythmogenic right ventricular cardiomyopathy	9/678	60/6026	0.22841294842688	0.693610354913827	0.582852818074866	87/2697/22801/3673/3678/8516/3690/3908/6444	9
WP3591	Sleep regulation	4/678	22/6026	0.229730818188019	0.693610354913827	0.582852818074866	134/3569/22871/4887	4
WP4842	Mammalian disorder of sexual development	3/678	15/6026	0.233950742449748	0.701852227349245	0.589778606510931	10468/2626/30812	3
WP536	Calcium regulation in cardiac cells	17/678	125/6026	0.23725850868009	0.707270617647609	0.594331773908819	147/777/816/2697/2701/2702/2707/127534/10052/59345/2791/51764/5350/64407/5999/8490/8787	17
WP4197	Immune response to tuberculosis	4/678	23/6026	0.255311390198554	0.740822942415266	0.622526374674579	8519/8651/6772/6890	4
WP4483	Relationship between inflammation, COX-2 and EGFR	4/678	23/6026	0.255311390198554	0.740822942415266	0.622526374674579	2099/4312/51365/5743	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/678	23/6026	0.255311390198554	0.740822942415266	0.622526374674579	29126/3458/4776/80380	4
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4/678	23/6026	0.255311390198554	0.740822942415266	0.622526374674579	3553/3569/10135/23057	4
WP3942	PPAR signaling pathway	8/678	54/6026	0.257733184405322	0.740822942415266	0.622526374674579	2180/2182/126129/4023/4312/4973/5346/28965	8
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/678	78/6026	0.25795108822952	0.740822942415266	0.622526374674579	8061/11211/283120/5328/4920/6422/6423/64321/7020/7472/7474	11
WP4241	Type 2 papillary renal cell carcinoma	5/678	31/6026	0.265762091843306	0.7586299712618	0.637489930035617	1513/3091/5155/7042/7043	5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10/678	72/6026	0.288072967178719	0.813423124314191	0.683533567420127	8061/11211/5328/4920/6422/6423/64321/83595/7472/7474	10
WP4542	Leukocyte-intrinsic Hippo pathway functions	5/678	32/6026	0.288411171465966	0.813423124314191	0.683533567420127	50943/26524/4023/639/7004	5
WP4655	Cytosolic DNA-sensing pathway	8/678	56/6026	0.291424601048906	0.817029685083541	0.686564223022486	834/6351/9560/3627/3553/90865/3569/81030	8
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3/678	17/6026	0.297844798127946	0.82520529363684	0.69343432876847	10631/3371/7472	3
WP4784	Proteoglycan biosynthesis	3/678	17/6026	0.297844798127946	0.82520529363684	0.69343432876847	9469/55790/1836	3
WP4217	Ebola virus infection in host	16/678	123/6026	0.306372019336735	0.833507587692633	0.700410890540687	87/432/684/11314/10332/93978/1514/26762/84868/3673/3678/3690/8503/9021/6772/7020	16
WP428	Wnt signaling	13/678	98/6026	0.306445711543478	0.833507587692633	0.700410890540687	816/8061/11211/4776/5328/23236/166336/4920/6422/6423/64321/7472/7474	13
WP4950	16p11.2 distal deletion syndrome	4/678	25/6026	0.307920000548871	0.833507587692633	0.700410890540687	1380/8519/3791/5350	4
WP581	EPO receptor signaling	4/678	25/6026	0.307920000548871	0.833507587692633	0.700410890540687	5163/10076/8651/6772	4
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2/678	10/6026	0.312586650794739	0.836524502979102	0.702946056811135	1116/9021	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/678	10/6026	0.312586650794739	0.836524502979102	0.702946056811135	1514/8829	2
WP3877	MYD88 distinct input-output pathway	3/678	18/6026	0.330215612802822	0.86406418683405	0.72608813107521	3552/7097/51311	3
WP4533	Transcription co-factors SKI and SKIL protein partners	3/678	18/6026	0.330215612802822	0.86406418683405	0.72608813107521	26524/23314/7004	3
WP4760	PKC-gamma calcium signaling pathway in ataxia	3/678	18/6026	0.330215612802822	0.86406418683405	0.72608813107521	2769/5163/23236	3
WP5149	Lipid metabolism in senescent cells	3/678	18/6026	0.330215612802822	0.86406418683405	0.72608813107521	50487/7941/5743	3
WP299	Nuclear receptors in lipid metabolism and toxicity	4/678	26/6026	0.334645266686379	0.870817240935274	0.731762839628256	19/8647/1594/1555	4
WP4658	Small cell lung cancer	12/678	93/6026	0.352327914595769	0.903475946520929	0.759206516687606	1282/1284/2335/3673/284217/3908/3910/3915/10319/4843/8503/5743	12
WP2586	Aryl hydrocarbon receptor pathway	6/678	43/6026	0.353503490994271	0.903475946520929	0.759206516687606	1543/1545/2099/4023/135112/5743	6
WP4947	Nitric oxide metabolism in cystic fibrosis	2/678	11/6026	0.355864105563608	0.903475946520929	0.759206516687606	4843/4846	2
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	2/678	11/6026	0.355864105563608	0.903475946520929	0.759206516687606	2358/5163	2
WP5102	Familial partial lipodystrophy (FPLD)	4/678	27/6026	0.361462715625926	0.903475946520929	0.759206516687606	2624/4023/5346/5396	4
WP3599	Transcription factor regulation in adipogenesis	3/678	19/6026	0.36254130338101	0.903475946520929	0.759206516687606	1051/3569/7291	3
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/678	19/6026	0.36254130338101	0.903475946520929	0.759206516687606	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/678	19/6026	0.36254130338101	0.903475946520929	0.759206516687606	2180/3651/55512	3
WP3945	TYROBP causal network in microglia	8/678	61/6026	0.379287141237959	0.933792302213823	0.784681876483177	3142/10261/3687/10008/4688/5341/6696/7305	8
WP2873	Aryl hydrocarbon receptor pathway	5/678	36/6026	0.381355774016721	0.933792302213823	0.784681876483177	1543/1545/3458/3553/8140	5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5/678	36/6026	0.381355774016721	0.933792302213823	0.784681876483177	684/8519/10581/10410/6196	5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/678	28/6026	0.388242725636508	0.933792302213823	0.784681876483177	3082/7042/7043/7474	4
WP4481	Resistin as a regulator of inflammation	4/678	28/6026	0.388242725636508	0.933792302213823	0.784681876483177	3569/23236/5333/113026	4
WP3640	Imatinib and chronic myeloid leukemia	3/678	20/6026	0.394610272535575	0.933792302213823	0.784681876483177	2321/5159/11040	3
WP3645	NAD+ biosynthetic pathways	3/678	20/6026	0.394610272535575	0.933792302213823	0.784681876483177	3620/10135/6999	3
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	6/678	45/6026	0.395542175137713	0.933792302213823	0.784681876483177	19/2180/2182/9023/54898/3992	6
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/678	12/6026	0.398119161941347	0.933792302213823	0.784681876483177	1634/6422	2
WP4211	Transcriptional cascade regulating adipogenesis	2/678	12/6026	0.398119161941347	0.933792302213823	0.784681876483177	1051/2624	2
WP5110	Familial hyperlipidemia type 3	2/678	12/6026	0.398119161941347	0.933792302213823	0.784681876483177	4023/7436	2
WP3888	VEGFA-VEGFR2 signaling pathway	48/678	409/6026	0.398497351900166	0.933792302213823	0.784681876483177	9510/56999/301/81575/22899/813/6347/1003/79094/2022/2078/24147/2321/2335/6624/2523/2624/2697/3142/5654/3383/3490/3690/3791/9079/4319/4323/4313/79812/4688/91624/4846/4855/8013/8828/5228/5328/5329/9588/5743/57381/27289/6401/6648/6772/7004/8794/81567	48
WP2876	Pregnane X receptor pathway	4/678	29/6026	0.41486593105363	0.962570707025909	0.808864869464168	1555/1577/1551/27286	4
WP4698	Vitamin D-sensitive calcium signaling in depression	4/678	29/6026	0.41486593105363	0.962570707025909	0.808864869464168	793/1594/2906/3786	4
WP4787	Osteoblast differentiation and related diseases	12/678	98/6026	0.423822124942434	0.978530494352383	0.822276155719066	2255/2247/2252/11211/2737/23493/4854/4855/8503/6772/7472/7474	12
WP383	Striated muscle contraction pathway	3/678	21/6026	0.426237843957299	0.979307436604331	0.822929033776352	59/4604/7134	3
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/678	13/6026	0.439034146542919	0.980265695095545	0.823734275016035	4312/5743	2
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2/678	13/6026	0.439034146542919	0.980265695095545	0.823734275016035	3690/7134	2
WP47	Hedgehog signaling pathway	2/678	13/6026	0.439034146542919	0.980265695095545	0.823734275016035	2737/6469	2
WP4942	15q13.3 copy number variation syndrome	2/678	13/6026	0.439034146542919	0.980265695095545	0.823734275016035	1139/871	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/678	13/6026	0.439034146542919	0.980265695095545	0.823734275016035	8647/9420	2
WP143	Fatty acid beta-oxidation	4/678	30/6026	0.441223624968695	0.980265695095545	0.823734275016035	2180/2182/8513/4023	4
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/678	30/6026	0.441223624968695	0.980265695095545	0.823734275016035	3624/6469/6615/7474	4
WP4806	EGFR tyrosine kinase inhibitor resistance	10/678	82/6026	0.444124240617858	0.982077546154981	0.825256804903951	2247/3082/3569/3791/22808/3084/5155/5159/8503/399694	10
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/678	65/6026	0.450715498845581	0.987381395145435	0.829713721253065	816/941/9076/1514/3690/4868/5329/7225	8
WP3303	RAC1/PAK1/p38/MMP2 pathway	8/678	65/6026	0.450715498845581	0.987381395145435	0.829713721253065	284/285/2335/4313/4843/7010/7075/79931	8
WP4537	Hippo-Yap signaling pathway	3/678	22/6026	0.457265269078765	0.992497427355291	0.834012811902089	3627/26524/7004	3
WP4595	Urea cycle and associated pathways	3/678	22/6026	0.457265269078765	0.992497427355291	0.834012811902089	4843/4846/5831	3
WP4222	Phosphodiesterases in neuronal function	5/678	40/6026	0.473878338102107	0.999999915904203	0.840317283227132	1139/2906/2977/10846/5142	5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/678	14/6026	0.478375608744838	0.999999915904203	0.840317283227132	3589/3569	2
WP4584	Biomarkers for pyrimidine metabolism disorders	2/678	14/6026	0.478375608744838	0.999999915904203	0.840317283227132	1152/1890	2
WP5061	Fatty acid transporters	2/678	14/6026	0.478375608744838	0.999999915904203	0.840317283227132	2180/2182	2
WP58	Monoamine GPCRs	2/678	14/6026	0.478375608744838	0.999999915904203	0.840317283227132	147/3274	2
WP697	Estrogen metabolism	2/678	14/6026	0.478375608744838	0.999999915904203	0.840317283227132	1543/1545	2
WP3845	Canonical and non-canonical Notch signaling	3/678	23/6026	0.487558350910797	0.999999915904203	0.840317283227132	4237/4854/4855	3
WP4545	Oxysterols derived from cholesterol	4/678	32/6026	0.492761748273384	0.999999915904203	0.840317283227132	9023/9420/2099/3605	4
WP2332	Interleukin-11 signaling pathway	5/678	41/6026	0.49638338609175	0.999999915904203	0.840317283227132	3383/3589/3673/9021/6772	5
WP2855	Dopaminergic neurogenesis	2/678	15/6026	0.515979434328698	0.999999915904203	0.840317283227132	6469/6571	2
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2/678	15/6026	0.515979434328698	0.999999915904203	0.840317283227132	1051/23657	2
WP5109	Familial hyperlipidemia type 2	2/678	15/6026	0.515979434328698	0.999999915904203	0.840317283227132	4023/255738	2
WP26	S1P receptor signal transduction	3/678	24/6026	0.517005813052936	0.999999915904203	0.840317283227132	23236/9294/8877	3
WP3529	Zinc homeostasis	4/678	33/6026	0.517778605788725	0.999999915904203	0.840317283227132	4494/4499/55532/29986	4
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/678	52/6026	0.538991876218433	0.999999915904203	0.840317283227132	308/79092/2149/3084/8767/9021	6
WP702	Metapathway biotransformation Phase I and II	14/678	125/6026	0.550209748634252	0.999999915904203	0.840317283227132	1645/9469/1543/1545/56603/1594/1555/1577/1551/9420/2328/64090/90161/4837	14
WP2884	NRF2 pathway	13/678	116/6026	0.550538696683704	0.999999915904203	0.840317283227132	874/3082/23764/3084/5155/9588/154091/6515/29986/160728/11254/23657/7042	13
WP3644	NAD+ metabolism	2/678	16/6026	0.55173823536428	0.999999915904203	0.840317283227132	10135/23057	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/678	16/6026	0.55173823536428	0.999999915904203	0.840317283227132	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/678	16/6026	0.55173823536428	0.999999915904203	0.840317283227132	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/678	16/6026	0.55173823536428	0.999999915904203	0.840317283227132	3569/64386	2
WP4970	Galanin receptor pathway	2/678	16/6026	0.55173823536428	0.999999915904203	0.840317283227132	3569/7020	2
WP4657	22q11.2 copy number variation syndrome	10/678	89/6026	0.55228449738019	0.999999915904203	0.840317283227132	59/150209/8854/9076/56603/2255/2296/9464/6469/7450	10
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/678	80/6026	0.553244438233643	0.999999915904203	0.840317283227132	50506/405753/3690/23236/5346/6469/6567/7068/7253	9
WP2359	Parkin-ubiquitin proteasomal system pathway	7/678	62/6026	0.556151890995337	0.999999915904203	0.840317283227132	834/2861/3310/6622/9627/347733/9246	7
WP4673	Male infertility	11/678	99/6026	0.565713710127959	0.999999915904203	0.840317283227132	1543/56603/2099/2346/219595/4313/4843/4846/29968/8787/6648	11
WP241	One-carbon metabolism	3/678	26/6026	0.573022590593469	0.999999915904203	0.840317283227132	10840/2346/219595	3
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3/678	26/6026	0.573022590593469	0.999999915904203	0.840317283227132	5744/6615/6772	3
WP195	IL-1 signaling pathway	6/678	54/6026	0.577381133763766	0.999999915904203	0.840317283227132	6347/3552/3553/3554/3556/11213	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5/678	45/6026	0.582217654839615	0.999999915904203	0.840317283227132	6356/3055/3559/3569/6772	5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/678	17/6026	0.585590693662458	0.999999915904203	0.840317283227132	87/3690	2
WP5074	Kallmann syndrome	2/678	17/6026	0.585590693662458	0.999999915904203	0.840317283227132	23129/60675	2
WP4249	Hedgehog signaling pathway	4/678	37/6026	0.611396786334846	0.999999915904203	0.840317283227132	91653/2619/2737/6469	4
WP497	Urea cycle and metabolism of amino groups	2/678	18/6026	0.617512578769913	0.999999915904203	0.840317283227132	1152/5831	2
WP5033	Genes associated with the development of rheumatoid arthritis	2/678	18/6026	0.617512578769913	0.999999915904203	0.840317283227132	3559/23569	2
WP286	IL-3 signaling pathway	5/678	47/6026	0.622058872732492	0.999999915904203	0.840317283227132	1232/942/1439/3055/3563	5
WP2895	Differentiation of white and brown adipocyte	2/678	19/6026	0.647509199403901	0.999999915904203	0.840317283227132	1051/253738	2
WP325	Triacylglyceride synthesis	2/678	19/6026	0.647509199403901	0.999999915904203	0.840317283227132	8513/4023	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/678	19/6026	0.647509199403901	0.999999915904203	0.840317283227132	8708/8877	2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2/678	19/6026	0.647509199403901	0.999999915904203	0.840317283227132	3091/5163	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/678	19/6026	0.647509199403901	0.999999915904203	0.840317283227132	53947/8877	2
WP3676	BDNF-TrkB signaling	3/678	29/6026	0.649039398325699	0.999999915904203	0.840317283227132	9456/4915/7225	3
WP3925	Amino acid metabolism	8/678	77/6026	0.649142939862474	0.999999915904203	0.840317283227132	127/586/3034/3067/5831/10993/6898/6999	8
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/678	30/6026	0.672130039809811	0.999999915904203	0.840317283227132	4846/5163/8503	3
WP3580	Methionine de novo and salvage pathway	2/678	20/6026	0.675609080167049	0.999999915904203	0.840317283227132	259307/6898	2
WP4224	Purine metabolism and related disorders	2/678	20/6026	0.675609080167049	0.999999915904203	0.840317283227132	270/316	2
WP2007	Iron metabolism in placenta	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	7018	1
WP3656	Interleukin-1 induced activation of NF-kB	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	3552	1
WP4259	Disorders of folate metabolism and transport	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	8647	1
WP5050	TCA cycle in senescence	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	5163	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/678	10/6026	0.697161492581328	0.999999915904203	0.840317283227132	629	1
WP262	Ebstein-Barr virus LMP1 signaling	2/678	21/6026	0.701858683978601	0.999999915904203	0.840317283227132	6364/9260	2
WP4905	1q21.1 copy number variation syndrome	2/678	21/6026	0.701858683978601	0.999999915904203	0.840317283227132	2697/2702	2
WP4963	p53 transcriptional gene network	8/678	81/6026	0.705317707200336	0.999999915904203	0.840317283227132	6347/126129/6376/55332/3383/4688/5054/23657	8
WP357	Fatty acid biosynthesis	2/678	22/6026	0.726318025468585	0.999999915904203	0.840317283227132	2180/2182	2
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2/678	22/6026	0.726318025468585	0.999999915904203	0.840317283227132	597/5744	2
WP229	Irinotecan pathway	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	1577	1
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	23236	1
WP3871	Valproic acid pathway	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	1555	1
WP3930	EDA signaling in hair follicle development	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	6469	1
WP4271	Vitamin B12 disorders	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	6947	1
WP4583	Biomarkers for urea cycle disorders	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	2155	1
WP4788	Autosomal recessive osteopetrosis pathways	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	29887	1
WP4919	Neuroinflammation	1/678	11/6026	0.7312912312831	0.999999915904203	0.840317283227132	4843	1
WP244	Alpha 6 beta 4 signaling pathway	3/678	33/6026	0.734624726731711	0.999999915904203	0.840317283227132	284217/3908/3915	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3/678	33/6026	0.734624726731711	0.999999915904203	0.840317283227132	816/9586/1511	3
WP1772	Apoptosis modulation and signaling	8/678	84/6026	0.743409364658567	0.999999915904203	0.840317283227132	597/638/834/8739/3554/4671/5783/8794	8
WP2267	Synaptic vesicle pathway	4/678	44/6026	0.745566393095088	0.999999915904203	0.840317283227132	6571/6507/6812/6853	4
WP34	Ovarian infertility	2/678	23/6026	0.749057042093136	0.999999915904203	0.840317283227132	1051/2701	2
WP4357	NRF2-ARE regulation	2/678	23/6026	0.749057042093136	0.999999915904203	0.840317283227132	1051/23657	2
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/678	23/6026	0.749057042093136	0.999999915904203	0.840317283227132	3569/114548	2
WP2023	Cell differentiation - expanded index	1/678	12/6026	0.761579601223259	0.999999915904203	0.840317283227132	10637	1
WP4792	Purine metabolism	1/678	12/6026	0.761579601223259	0.999999915904203	0.840317283227132	270	1
WP5112	Familial hyperlipidemia type 5	1/678	12/6026	0.761579601223259	0.999999915904203	0.840317283227132	4023	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2/678	24/6026	0.770152608369518	0.999999915904203	0.840317283227132	247/2358	2
WP4925	Unfolded protein response	2/678	24/6026	0.770152608369518	0.999999915904203	0.840317283227132	3553/7494	2
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/678	24/6026	0.770152608369518	0.999999915904203	0.840317283227132	2769/23236	2
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4/678	46/6026	0.776653476126208	0.999999915904203	0.840317283227132	5163/8503/11040/6196	4
WP61	Notch signaling pathway	5/678	57/6026	0.784289373670052	0.999999915904203	0.840317283227132	1840/23493/3091/4854/4855	5
WP2289	Drug induction of bile acid pathway	1/678	13/6026	0.788458389113287	0.999999915904203	0.840317283227132	8647	1
WP3853	ERK pathway in Huntington's disease	1/678	13/6026	0.788458389113287	0.999999915904203	0.840317283227132	4915	1
WP5108	Familial  hyperlipidemia type 1	1/678	13/6026	0.788458389113287	0.999999915904203	0.840317283227132	4023	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/678	13/6026	0.788458389113287	0.999999915904203	0.840317283227132	3091	1
WP1528	Physiological and pathological hypertrophy of the heart	2/678	25/6026	0.789686094770516	0.999999915904203	0.840317283227132	2626/4776	2
WP205	IL-7 signaling pathway	2/678	25/6026	0.789686094770516	0.999999915904203	0.840317283227132	3559/6772	2
WP3613	Photodynamic therapy-induced unfolded protein response	2/678	25/6026	0.789686094770516	0.999999915904203	0.840317283227132	121506/7494	2
WP430	Statin inhibition of cholesterol production	2/678	25/6026	0.789686094770516	0.999999915904203	0.840317283227132	19/4023	2
WP1403	AMP-activated protein kinase (AMPK) signaling	5/678	58/6026	0.797054734629069	0.999999915904203	0.840317283227132	147/126129/5209/8503/23236	5
WP4262	Breast cancer pathway	12/678	129/6026	0.799433029378085	0.999999915904203	0.840317283227132	2099/2255/2247/2252/11211/23493/4854/4855/8503/399694/7472/7474	12
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2/678	26/6026	0.80774138678527	0.999999915904203	0.840317283227132	1051/2099	2
WP3851	TLR4 signaling and tolerance	2/678	26/6026	0.80774138678527	0.999999915904203	0.840317283227132	3569/11213	2
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/678	26/6026	0.80774138678527	0.999999915904203	0.840317283227132	4915/8503	2
WP2879	Farnesoid X receptor pathway	1/678	14/6026	0.812310910680091	0.999999915904203	0.840317283227132	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/678	14/6026	0.812310910680091	0.999999915904203	0.840317283227132	283120	1
WP4758	Nephrotic syndrome	3/678	38/6026	0.817409146269398	0.999999915904203	0.840317283227132	8542/4868/7225	3
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4/678	49/6026	0.817563361768479	0.999999915904203	0.840317283227132	2252/3458/3569/4313	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4/678	49/6026	0.817563361768479	0.999999915904203	0.840317283227132	1051/1513/6696/7042	4
WP5098	T-cell activation SARS-CoV-2	7/678	81/6026	0.821289219239985	0.999999915904203	0.840317283227132	941/942/3458/3595/3605/8809/3937	7
WP2112	IL-17 signaling pathway	2/678	27/6026	0.824403291730939	0.999999915904203	0.840317283227132	1051/3605	2
WP2643	Nanoparticle-mediated activation of receptor signaling	2/678	27/6026	0.824403291730939	0.999999915904203	0.840317283227132	1277/2335	2
WP2875	Constitutive androstane receptor pathway	2/678	27/6026	0.824403291730939	0.999999915904203	0.840317283227132	1555/1577	2
WP2526	PDGF pathway	3/678	39/6026	0.831046147897161	0.999999915904203	0.840317283227132	5155/5159/6772	3
WP2828	Bladder cancer	3/678	39/6026	0.831046147897161	0.999999915904203	0.840317283227132	4312/4313/1890	3
WP4313	Ferroptosis	5/678	61/6026	0.83180254800551	0.999999915904203	0.840317283227132	2180/2182/1645/23657/7018	5
WP4962	Airway smooth muscle cell contraction	1/678	15/6026	0.833477444705191	0.999999915904203	0.840317283227132	23236	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/678	15/6026	0.833477444705191	0.999999915904203	0.840317283227132	3091	1
WP4150	Wnt signaling in kidney disease	2/678	28/6026	0.839756271334568	0.999999915904203	0.840317283227132	7472/7474	2
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/678	28/6026	0.839756271334568	0.999999915904203	0.840317283227132	59/9104	2
WP5224	2q37 copy number variation syndrome	9/678	104/6026	0.842418749378314	0.999999915904203	0.840317283227132	19/10203/1293/6373/64090/3553/3690/129807/3651	9
WP3940	One-carbon metabolism and related pathways	3/678	40/6026	0.843799683048639	0.999999915904203	0.840317283227132	586/23743/6648	3
WP4312	Rett syndrome causing genes	3/678	40/6026	0.843799683048639	0.999999915904203	0.840317283227132	23314/85358/6812	3
WP395	IL-4 signaling pathway	4/678	52/6026	0.852107406890006	0.999999915904203	0.840317283227132	1051/8651/9021/6772	4
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1/678	16/6026	0.852260058661251	0.999999915904203	0.840317283227132	19	1
WP22	IL-9 signaling pathway	1/678	16/6026	0.852260058661251	0.999999915904203	0.840317283227132	6772	1
WP4225	Pyrimidine metabolism and related diseases	1/678	16/6026	0.852260058661251	0.999999915904203	0.840317283227132	1890	1
WP4912	SARS coronavirus and innate immunity	1/678	16/6026	0.852260058661251	0.999999915904203	0.840317283227132	6772	1
WP3972	PDGFR-beta pathway	2/678	29/6026	0.853883447113003	0.999999915904203	0.840317283227132	5159/6772	2
WP408	Oxidative stress response	2/678	29/6026	0.853883447113003	0.999999915904203	0.840317283227132	1543/6648	2
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2/678	29/6026	0.853883447113003	0.999999915904203	0.840317283227132	6772/7097	2
WP268	Notch signaling	3/678	41/6026	0.85571063758985	0.999999915904203	0.840317283227132	1840/4854/4855	3
WP4290	Metabolic reprogramming in colon cancer	3/678	41/6026	0.85571063758985	0.999999915904203	0.840317283227132	3101/29968/5831	3
WP49	IL-2 signaling pathway	3/678	41/6026	0.85571063758985	0.999999915904203	0.840317283227132	3559/9021/6772	3
WP2034	Leptin signaling pathway	6/678	75/6026	0.862821685789777	0.999999915904203	0.840317283227132	2099/3553/3557/4846/9021/6772	6
WP69	T-cell receptor signaling pathway	7/678	86/6026	0.865279663864679	0.999999915904203	0.840317283227132	3601/3605/3552/3553/3569/3937/8767	7
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3/678	42/6026	0.866820180306329	0.999999915904203	0.840317283227132	59/3690/7004	3
WP4917	Proximal tubule transport	3/678	42/6026	0.866820180306329	0.999999915904203	0.840317283227132	760/762/160728	3
WP3858	Toll-like receptor signaling related to MyD88	2/678	30/6026	0.866865833348945	0.999999915904203	0.840317283227132	7097/51311	2
WP4149	White fat cell differentiation	2/678	30/6026	0.866865833348945	0.999999915904203	0.840317283227132	1051/2624	2
WP5111	Familial hyperlipidemia type 4	1/678	17/6026	0.868926893973676	0.999999915904203	0.840317283227132	4023	1
WP5200	Dravet syndrome	1/678	17/6026	0.868926893973676	0.999999915904203	0.840317283227132	6324	1
WP2853	Endoderm differentiation	10/678	118/6026	0.869316269226651	0.999999915904203	0.840317283227132	1846/2626/3227/3915/5744/6422/154091/64321/83595/6772	10
WP2018	RANKL/RANK signaling pathway	4/678	54/6026	0.871922564522704	0.999999915904203	0.840317283227132	1513/3383/6688/6772	4
WP399	Wnt signaling pathway and pluripotency	7/678	87/6026	0.872920674410894	0.999999915904203	0.840317283227132	8061/11211/120892/4316/5328/7472/7474	7
WP1971	Integrated cancer pathway	3/678	43/6026	0.877169376562325	0.999999915904203	0.840317283227132	994/4312/6772	3
WP3298	Melatonin metabolism and effects	2/678	31/6026	0.878781759157279	0.999999915904203	0.840317283227132	1543/1545	2
WP4844	Influence of laminopathies on Wnt signaling	2/678	31/6026	0.878781759157279	0.999999915904203	0.840317283227132	1051/6696	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/678	31/6026	0.878781759157279	0.999999915904203	0.840317283227132	5163/23236	2
WP366	TGF-beta signaling pathway	11/678	130/6026	0.879721367838707	0.999999915904203	0.840317283227132	1278/2335/2354/50943/3673/3690/4312/4321/5163/7015/3371	11
WP4223	Ras signaling	14/678	161/6026	0.881175912715268	0.999999915904203	0.840317283227132	2321/59345/2791/51764/3791/22808/4915/5159/8503/51365/50487/115727/399694/7010	14
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/678	18/6026	0.883715971338603	0.999999915904203	0.840317283227132	22808	1
WP4971	Phosphoinositides metabolism	3/678	44/6026	0.886798863157488	0.999999915904203	0.840317283227132	23236/5333/113026	3
WP1584	Type II diabetes mellitus	1/678	19/6026	0.89683856977942	0.999999915904203	0.840317283227132	3651	1
WP5103	Progeria-associated lipodystrophy	1/678	19/6026	0.89683856977942	0.999999915904203	0.840317283227132	2200	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/678	19/6026	0.89683856977942	0.999999915904203	0.840317283227132	2626	1
WP3981	miRNA regulation of prostate cancer signaling pathways	2/678	33/6026	0.899711719169408	0.999999915904203	0.840317283227132	354/5159	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	6/678	80/6026	0.89994582347058	0.999999915904203	0.840317283227132	2247/2626/4776/3084/8503/7474	6
WP3931	Embryonic stem cell pluripotency pathways	7/678	91/6026	0.89998411054675	0.999999915904203	0.840317283227132	2255/2247/2252/5155/5159/7472/7474	7
WP5180	DYRK1A	4/678	58/6026	0.904769044007124	0.999999915904203	0.840317283227132	273/2247/3092/26524	4
WP710	DNA damage response (only ATM dependent)	8/678	103/6026	0.906544463492259	0.999999915904203	0.840317283227132	638/8061/5163/8503/5328/6648/7472/7474	8
WP2878	PPAR-alpha pathway	1/678	20/6026	0.908482227127439	0.999999915904203	0.840317283227132	55554	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/678	20/6026	0.908482227127439	0.999999915904203	0.840317283227132	3002	1
WP4725	Sphingolipid metabolism overview	1/678	20/6026	0.908482227127439	0.999999915904203	0.840317283227132	8877	1
WP170	Nuclear receptors	2/678	34/6026	0.908865810805392	0.999999915904203	0.840317283227132	2099/7068	2
WP400	p38 MAPK signaling pathway	2/678	34/6026	0.908865810805392	0.999999915904203	0.840317283227132	6772/7042	2
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4/678	59/6026	0.911718100232416	0.999999915904203	0.840317283227132	1437/3458/3937/5163	4
WP185	Integrin-mediated cell adhesion	7/678	94/6026	0.916924011565943	0.999999915904203	0.840317283227132	11131/22801/3673/3678/8516/3687/3690	7
WP4630	Measles virus infection	9/678	116/6026	0.917662930618767	0.999999915904203	0.840317283227132	10332/3310/3552/3553/3559/3569/8503/6772/7097	9
WP382	MAPK signaling pathway	18/678	210/6026	0.917665418049414	0.999999915904203	0.840317283227132	777/994/1846/2255/2247/2252/3310/3552/3553/3554/120892/22808/4915/5155/5159/115727/7042/7043	18
WP4288	MTHFR deficiency	1/678	21/6026	0.918813404284881	0.999999915904203	0.840317283227132	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/678	21/6026	0.918813404284881	0.999999915904203	0.840317283227132	8877	1
WP51	Regulation of actin cytoskeleton	10/678	127/6026	0.918813785265871	0.999999915904203	0.840317283227132	87/2149/2255/2247/2252/2335/22808/5155/5159/8503	10
WP2447	Amyotrophic lateral sclerosis (ALS)	2/678	36/6026	0.924874904382237	0.999999915904203	0.840317283227132	834/4741	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/678	36/6026	0.924874904382237	0.999999915904203	0.840317283227132	3488/5163	2
WP623	Oxidative phosphorylation	2/678	36/6026	0.924874904382237	0.999999915904203	0.840317283227132	3002/56901	2
WP2272	Pathogenic Escherichia coli infection	3/678	49/6026	0.925512781551421	0.999999915904203	0.840317283227132	9076/23643/347733	3
WP2637	Interleukin-1 (IL-1) structural pathway	3/678	49/6026	0.925512781551421	0.999999915904203	0.840317283227132	3552/3554/3556	3
WP363	Wnt signaling pathway	3/678	49/6026	0.925512781551421	0.999999915904203	0.840317283227132	2697/4920/7010	3
WP4482	Vitamin D in inflammatory diseases	1/678	22/6026	0.927979850895181	0.999999915904203	0.840317283227132	3569	1
WP4686	Leucine, isoleucine and valine metabolism	1/678	22/6026	0.927979850895181	0.999999915904203	0.840317283227132	586	1
WP712	Estrogen signaling pathway	1/678	22/6026	0.927979850895181	0.999999915904203	0.840317283227132	2099	1
WP4932	7q11.23 copy number variation syndrome	6/678	86/6026	0.932820739228542	0.999999915904203	0.840317283227132	9076/2199/2200/3084/9246/7472	6
WP2037	Prolactin signaling pathway	5/678	75/6026	0.935569782854918	0.999999915904203	0.840317283227132	4843/6196/8651/9021/6772	5
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/678	23/6026	0.936112705840729	0.999999915904203	0.840317283227132	5054	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/678	23/6026	0.936112705840729	0.999999915904203	0.840317283227132	3290	1
WP3286	Copper homeostasis	3/678	51/6026	0.937272777464183	0.999999915904203	0.840317283227132	4494/26872/79689	3
WP500	Glycogen synthesis and degradation	2/678	38/6026	0.938205545303487	0.999999915904203	0.840317283227132	3101/5255	2
WP4906	3q29 copy number variation syndrome	3/678	52/6026	0.942486983825867	0.999999915904203	0.840317283227132	3091/8503/7018	3
WP127	IL-5 signaling pathway	2/678	39/6026	0.943997945163288	0.999999915904203	0.840317283227132	1439/6772	2
WP534	Glycolysis and gluconeogenesis	2/678	39/6026	0.943997945163288	0.999999915904203	0.840317283227132	3101/6515	2
WP4549	Fragile X syndrome	7/678	101/6026	0.947106580441807	0.999999915904203	0.840317283227132	816/80852/9456/4131/4915/5163/23236	7
WP585	Interferon type I signaling pathways	3/678	53/6026	0.947297041189608	0.999999915904203	0.840317283227132	8651/9021/6772	3
WP2355	Corticotropin-releasing hormone signaling pathway	5/678	78/6026	0.948346357936403	0.999999915904203	0.840317283227132	2354/8061/2697/4846/7020	5
WP1422	Sphingolipid pathway	1/678	25/6026	0.949730123397604	0.999999915904203	0.840317283227132	8877	1
WP3965	Lipid metabolism pathway	1/678	25/6026	0.949730123397604	0.999999915904203	0.840317283227132	5346	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	2/678	41/6026	0.954069532794181	0.999999915904203	0.840317283227132	3552/8767	2
WP5038	Mitochondrial immune response to SARS-CoV-2	1/678	26/6026	0.955409672862097	0.999999915904203	0.840317283227132	1514	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2/678	42/6026	0.958432000418573	0.999999915904203	0.840317283227132	6347/3569	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/678	42/6026	0.958432000418573	0.999999915904203	0.840317283227132	7042/7043	2
WP2525	Trans-sulfuration and one-carbon metabolism	1/678	27/6026	0.96044837982868	0.999999915904203	0.840317283227132	29968	1
WP3869	Cannabinoid receptor signaling	1/678	27/6026	0.96044837982868	0.999999915904203	0.840317283227132	1543	1
WP3996	Ethanol effects on histone modifications	1/678	27/6026	0.96044837982868	0.999999915904203	0.840317283227132	8854	1
WP4204	Tumor suppressor activity of SMARCB1	1/678	27/6026	0.96044837982868	0.999999915904203	0.840317283227132	2737	1
WP410	Exercise-induced circadian regulation	2/678	43/6026	0.962396030850585	0.999999915904203	0.840317283227132	1051/50486	2
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	4/678	70/6026	0.963103122994262	0.999999915904203	0.840317283227132	9423/5743/7042/7043	4
WP5205	Clock-controlled autophagy in bone metabolism	4/678	70/6026	0.963103122994262	0.999999915904203	0.840317283227132	115908/1513/3569/7474	4
WP673	ErbB signaling pathway	5/678	83/6026	0.964630944567145	0.999999915904203	0.840317283227132	816/3084/145957/8503/399694	5
WP2583	T cell receptor and co-stimulatory signaling	1/678	28/6026	0.964918457921055	0.999999915904203	0.840317283227132	5163	1
WP2038	Microtubule cytoskeleton regulation	2/678	44/6026	0.965995895978828	0.999999915904203	0.840317283227132	2151/4131	2
WP4255	Non-small cell lung cancer	4/678	71/6026	0.966024776712548	0.999999915904203	0.840317283227132	1381/1382/5163/8503	4
WP3680	Physico-chemical features and toxicity-associated pathways	3/678	58/6026	0.966208995936813	0.999999915904203	0.840317283227132	2335/11211/4741	3
WP4659	Gastrin signaling pathway	7/678	108/6026	0.967113052853355	0.999999915904203	0.840317283227132	9076/3067/4316/8503/5743/5054/7032	7
WP1601	Fluoropyrimidine activity	1/678	29/6026	0.968883994021342	0.999999915904203	0.840317283227132	1890	1
WP183	Proteasome degradation	3/678	59/6026	0.969128151063834	0.999999915904203	0.840317283227132	3458/5698/7345	3
WP304	Kit receptor signaling pathway	3/678	59/6026	0.969128151063834	0.999999915904203	0.840317283227132	6615/8651/6772	3
WP4321	Thermogenesis	6/678	98/6026	0.971370168865992	0.999999915904203	0.840317283227132	2180/2182/126129/9586/5346/6196	6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	9/678	134/6026	0.972636827453182	0.999999915904203	0.840317283227132	249/55816/4688/4776/4915/399694/6696/6772/6853	9
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/678	31/6026	0.975522531713184	0.999999915904203	0.840317283227132	4776	1
WP4396	Nonalcoholic fatty liver disease	9/678	137/6026	0.977521998550673	0.999999915904203	0.840317283227132	6347/84701/3552/3553/3569/56901/8503/9021/7494	9
WP3995	Prion disease pathway	1/678	32/6026	0.978290792513594	0.999999915904203	0.840317283227132	6688	1
WP3998	Prader-Willi and Angelman syndrome	1/678	32/6026	0.978290792513594	0.999999915904203	0.840317283227132	4948	1
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	1/678	32/6026	0.978290792513594	0.999999915904203	0.840317283227132	6772	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3/678	64/6026	0.980478392222166	0.999999915904203	0.840317283227132	23236/6772/7253	3
WP2059	Alzheimer's disease and miRNA effects	17/678	229/6026	0.980605724973343	0.999999915904203	0.840317283227132	1139/11211/2906/3552/3553/3569/4023/407024/4843/8503/23236/5743/6622/347733/7472/7474/7494	17
WP4874	CAMKK2 pathway	1/678	33/6026	0.9807463885556	0.999999915904203	0.840317283227132	3383	1
WP313	Hepatocyte growth factor receptor signaling	1/678	34/6026	0.982924587881364	0.999999915904203	0.840317283227132	3082	1
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2/678	52/6026	0.984994798457506	0.999999915904203	0.840317283227132	3627/3458	2
WP4949	16p11.2 proximal deletion syndrome	3/678	67/6026	0.985243777459411	0.999999915904203	0.840317283227132	253982/2099/653808	3
WP2795	Cardiac hypertrophic response	2/678	53/6026	0.986473141879777	0.999999915904203	0.840317283227132	2247/3084	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/678	53/6026	0.986473141879777	0.999999915904203	0.840317283227132	3082/8503	2
WP4666	Hepatitis B infection	8/678	133/6026	0.986912242246443	0.999999915904203	0.840317283227132	9586/3569/4776/8503/6772/7042/7043/7097	8
WP3594	Circadian rhythm genes	10/678	157/6026	0.987066294819266	0.999999915904203	0.840317283227132	134/2155/9456/3569/10135/22871/4843/4887/60675/5054	10
WP2857	Mesodermal commitment pathway	7/678	121/6026	0.987124535261311	0.999999915904203	0.840317283227132	2296/3624/10637/4211/154091/6615/64321	7
WP5124	Alzheimer's disease	16/678	226/6026	0.98757214460762	0.999999915904203	0.840317283227132	1139/11211/2906/3552/3553/3569/4023/4843/8503/23236/5743/6622/347733/7472/7474/7494	16
WP2516	ATM signaling pathway	1/678	37/6026	0.988090523276672	0.999999915904203	0.840317283227132	8120	1
WP4148	Splicing factor NOVA regulated synaptic proteins	1/678	37/6026	0.988090523276672	0.999999915904203	0.840317283227132	2898	1
WP35	G protein signaling pathways	4/678	85/6026	0.989775361987877	0.999999915904203	0.840317283227132	2769/2791/51764/5142	4
WP3584	MECP2 and associated Rett syndrome	2/678	56/6026	0.990107213259543	0.999999915904203	0.840317283227132	2247/6890	2
WP5085	Vasopressin-regulated water reabsorption	1/678	39/6026	0.990634576997262	0.999999915904203	0.840317283227132	9586	1
WP4263	Pancreatic adenocarcinoma pathway	4/678	87/6026	0.99144055611309	0.999999915904203	0.840317283227132	8503/6772/7042/7043	4
WP5220	Metabolic reprogramming in pancreatic cancer	1/678	41/6026	0.992635808616913	0.999999915904203	0.840317283227132	8140	1
WP5072	Modulators of TCR signaling and T cell activation	2/678	59/6026	0.9927823077907	0.999999915904203	0.840317283227132	3937/8651	2
WP481	Insulin signaling	9/678	156/6026	0.993994768373255	0.999999915904203	0.840317283227132	30846/8503/57381/6196/10110/8651/9021/6812/7494	9
WP4155	Endometrial cancer	2/678	61/6026	0.994157735440087	0.999999915904203	0.840317283227132	2247/8503	2
WP437	EGF/EGFR signaling pathway	9/678	157/6026	0.994416094467754	0.999999915904203	0.840317283227132	54206/2354/2697/4846/7837/6196/6772/6812/7291	9
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/678	44/6026	0.994866045142377	0.999999915904203	0.840317283227132	7494	1
WP4685	Melanoma	2/678	63/6026	0.995275447023432	0.999999915904203	0.840317283227132	3791/8503	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	6/678	125/6026	0.996614925965112	0.999999915904203	0.840317283227132	1555/4023/8503/6196/6567/7068	6
WP254	Apoptosis	3/678	84/6026	0.997144839953516	0.999999915904203	0.840317283227132	834/3002/8739	3
WP4656	Joubert syndrome	2/678	71/6026	0.997996320606273	0.999999915904203	0.840317283227132	27077/6469	2
WP231	TNF-alpha signaling pathway	3/678	92/6026	0.998717454920282	0.999999915904203	0.840317283227132	6347/3569/6401	3
WP3651	Pathways affected in adenoid cystic carcinoma	1/678	58/6026	0.999048944910688	0.999999915904203	0.840317283227132	4603	1
WP2261	Glioblastoma signaling pathways	2/678	82/6026	0.9993954128655	0.999999915904203	0.840317283227132	54206/5159	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/678	66/6026	0.99963779107033	0.999999915904203	0.840317283227132	4023	1
WP4536	Genes related to primary cilium development (based on CRISPR)	2/678	88/6026	0.999687907274383	0.999999915904203	0.840317283227132	27077/23552	2
WP4674	Head and neck squamous cell carcinoma	1/678	72/6026	0.999824558802571	0.999999915904203	0.840317283227132	7015	1
WP179	Cell cycle	3/678	115/6026	0.999880516441783	0.999999915904203	0.840317283227132	994/7042/7043	3
WP4022	Pyrimidine metabolism	1/678	79/6026	0.999924767363232	0.999999915904203	0.840317283227132	1890	1
WP138	Androgen receptor signaling pathway	1/678	85/6026	0.999963621331727	0.999999915904203	0.840317283227132	354	1
WP2446	Retinoblastoma gene in cancer	1/678	86/6026	0.999967772945444	0.999999915904203	0.840317283227132	994	1
WP477	Cytoplasmic ribosomal proteins	1/678	86/6026	0.999967772945444	0.999999915904203	0.840317283227132	6196	1
WP4803	Ciliopathies	3/678	138/6026	0.999989749227223	0.999999915904203	0.840317283227132	27077/10309/2737	3
WP23	B cell receptor signaling pathway	1/678	96/6026	0.999990418352378	0.999999915904203	0.840317283227132	1380	1
WP4352	Ciliary landscape	4/678	201/6026	0.999999915904203	0.999999915904203	0.840317283227132	3934/4741/7020/7022	4
